NASDAQ:MLAB

Mesa Laboratories Competitors

$257.33
+5.06 (+2.01 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$252.19
Now: $257.33
$259.58
50-Day Range
$235.00
MA: $256.94
$278.52
52-Week Range
$207.54
Now: $257.33
$307.97
Volume42,861 shs
Average Volume27,683 shs
Market Capitalization$1.32 billion
P/E RatioN/A
Dividend Yield0.27%
Beta0.39

Competitors

Mesa Laboratories (NASDAQ:MLAB) Vs. CGNX, FLIR, COHR, NATI, ITRI, and BMI

Should you be buying MLAB stock or one of its competitors? Companies in the sub-industry of "electronic equipment & instruments" are considered alternatives and competitors to Mesa Laboratories, including Cognex (CGNX), FLIR Systems (FLIR), Coherent (COHR), National Instruments (NATI), Itron (ITRI), and Badger Meter (BMI).

Cognex (NASDAQ:CGNX) and Mesa Laboratories (NASDAQ:MLAB) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Insider & Institutional Ownership

91.5% of Cognex shares are held by institutional investors. Comparatively, 93.5% of Mesa Laboratories shares are held by institutional investors. 5.2% of Cognex shares are held by company insiders. Comparatively, 6.1% of Mesa Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Cognex and Mesa Laboratories' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cognex$725.63 million20.26$203.87 million$1.1671.75
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12

Cognex has higher revenue and earnings than Mesa Laboratories. Mesa Laboratories is trading at a lower price-to-earnings ratio than Cognex, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Cognex and Mesa Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cognex24.72%13.45%9.64%
Mesa Laboratories-2.04%6.39%3.91%

Volatility & Risk

Cognex has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Comparatively, Mesa Laboratories has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations for Cognex and Mesa Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cognex33402.10
Mesa Laboratories02002.00

Cognex currently has a consensus price target of $68.7778, indicating a potential downside of 17.36%. Mesa Laboratories has a consensus price target of $273.50, indicating a potential upside of 6.28%. Given Mesa Laboratories' higher possible upside, analysts plainly believe Mesa Laboratories is more favorable than Cognex.

Dividends

Cognex pays an annual dividend of $0.24 per share and has a dividend yield of 0.3%. Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.2%. Cognex pays out 20.7% of its earnings in the form of a dividend. Mesa Laboratories pays out 15.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cognex has raised its dividend for 5 consecutive years and Mesa Laboratories has raised its dividend for 1 consecutive years. Cognex is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cognex beats Mesa Laboratories on 12 of the 17 factors compared between the two stocks.

Mesa Laboratories (NASDAQ:MLAB) and FLIR Systems (NASDAQ:FLIR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Insider & Institutional Ownership

93.5% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 88.7% of FLIR Systems shares are owned by institutional investors. 6.1% of Mesa Laboratories shares are owned by company insiders. Comparatively, 1.6% of FLIR Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Mesa Laboratories and FLIR Systems' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12
FLIR Systems$1.89 billion4.03$171.60 million$2.2326.00

FLIR Systems has higher revenue and earnings than Mesa Laboratories. FLIR Systems is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mesa Laboratories and FLIR Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mesa Laboratories-2.04%6.39%3.91%
FLIR Systems7.36%16.85%9.52%

Risk & Volatility

Mesa Laboratories has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, FLIR Systems has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mesa Laboratories and FLIR Systems, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mesa Laboratories02002.00
FLIR Systems16102.00

Mesa Laboratories presently has a consensus target price of $273.50, indicating a potential upside of 6.28%. FLIR Systems has a consensus target price of $52.20, indicating a potential downside of 9.98%. Given Mesa Laboratories' higher probable upside, equities research analysts plainly believe Mesa Laboratories is more favorable than FLIR Systems.

Dividends

Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.2%. FLIR Systems pays an annual dividend of $0.68 per share and has a dividend yield of 1.2%. Mesa Laboratories pays out 15.2% of its earnings in the form of a dividend. FLIR Systems pays out 30.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Mesa Laboratories has raised its dividend for 1 consecutive years and FLIR Systems has raised its dividend for 1 consecutive years.

Summary

FLIR Systems beats Mesa Laboratories on 9 of the 15 factors compared between the two stocks.

Mesa Laboratories (NASDAQ:MLAB) and Coherent (NASDAQ:COHR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Institutional & Insider Ownership

93.5% of Mesa Laboratories shares are held by institutional investors. Comparatively, 91.8% of Coherent shares are held by institutional investors. 6.1% of Mesa Laboratories shares are held by insiders. Comparatively, 0.6% of Coherent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Mesa Laboratories and Coherent's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12
Coherent$1.23 billion5.35$-414,140,000.00$1.44186.57

Mesa Laboratories has higher earnings, but lower revenue than Coherent. Mesa Laboratories is trading at a lower price-to-earnings ratio than Coherent, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mesa Laboratories and Coherent's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mesa Laboratories-2.04%6.39%3.91%
Coherent-33.70%3.41%1.81%

Risk and Volatility

Mesa Laboratories has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Coherent has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mesa Laboratories and Coherent, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mesa Laboratories02002.00
Coherent07302.30

Mesa Laboratories presently has a consensus target price of $273.50, indicating a potential upside of 6.28%. Coherent has a consensus target price of $169.00, indicating a potential downside of 37.10%. Given Mesa Laboratories' higher probable upside, equities research analysts plainly believe Mesa Laboratories is more favorable than Coherent.

Summary

Mesa Laboratories beats Coherent on 9 of the 14 factors compared between the two stocks.

Mesa Laboratories (NASDAQ:MLAB) and National Instruments (NASDAQ:NATI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Insider & Institutional Ownership

93.5% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 86.1% of National Instruments shares are owned by institutional investors. 6.1% of Mesa Laboratories shares are owned by company insiders. Comparatively, 1.9% of National Instruments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Mesa Laboratories and National Instruments' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12
National Instruments$1.35 billion4.30$162.15 million$1.3133.76

National Instruments has higher revenue and earnings than Mesa Laboratories. National Instruments is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mesa Laboratories and National Instruments' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mesa Laboratories-2.04%6.39%3.91%
National Instruments15.35%10.01%6.99%

Risk & Volatility

Mesa Laboratories has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, National Instruments has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mesa Laboratories and National Instruments, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mesa Laboratories02002.00
National Instruments14102.00

Mesa Laboratories presently has a consensus target price of $273.50, indicating a potential upside of 6.28%. National Instruments has a consensus target price of $40.8333, indicating a potential downside of 7.68%. Given Mesa Laboratories' higher probable upside, equities research analysts plainly believe Mesa Laboratories is more favorable than National Instruments.

Dividends

Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.2%. National Instruments pays an annual dividend of $1.08 per share and has a dividend yield of 2.4%. Mesa Laboratories pays out 15.2% of its earnings in the form of a dividend. National Instruments pays out 82.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Mesa Laboratories has raised its dividend for 1 consecutive years and National Instruments has raised its dividend for 1 consecutive years.

Summary

National Instruments beats Mesa Laboratories on 9 of the 15 factors compared between the two stocks.

Mesa Laboratories (NASDAQ:MLAB) and Itron (NASDAQ:ITRI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Institutional & Insider Ownership

93.5% of Mesa Laboratories shares are held by institutional investors. Comparatively, 96.5% of Itron shares are held by institutional investors. 6.1% of Mesa Laboratories shares are held by insiders. Comparatively, 1.7% of Itron shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Mesa Laboratories and Itron's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12
Itron$2.50 billion1.61$49.01 million$3.3226.95

Itron has higher revenue and earnings than Mesa Laboratories. Itron is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Mesa Laboratories and Itron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mesa Laboratories-2.04%6.39%3.91%
Itron-2.85%9.74%2.64%

Risk and Volatility

Mesa Laboratories has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Itron has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mesa Laboratories and Itron, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mesa Laboratories02002.00
Itron111002.75

Mesa Laboratories presently has a consensus target price of $273.50, indicating a potential upside of 6.28%. Itron has a consensus target price of $97.4545, indicating a potential upside of 8.91%. Given Itron's stronger consensus rating and higher probable upside, analysts plainly believe Itron is more favorable than Mesa Laboratories.

Summary

Itron beats Mesa Laboratories on 9 of the 14 factors compared between the two stocks.

Mesa Laboratories (NASDAQ:MLAB) and Badger Meter (NYSE:BMI) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mesa Laboratories and Badger Meter, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Mesa Laboratories02002.00
Badger Meter13102.00

Mesa Laboratories presently has a consensus target price of $273.50, indicating a potential upside of 6.28%. Badger Meter has a consensus target price of $72.80, indicating a potential downside of 23.49%. Given Mesa Laboratories' higher probable upside, equities research analysts plainly believe Mesa Laboratories is more favorable than Badger Meter.

Earnings and Valuation

This table compares Mesa Laboratories and Badger Meter's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$117.69 million11.22$1.35 million$4.2161.12
Badger Meter$424.63 million6.53$47.18 million$1.6159.10

Badger Meter has higher revenue and earnings than Mesa Laboratories. Badger Meter is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

93.5% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 85.9% of Badger Meter shares are owned by institutional investors. 6.1% of Mesa Laboratories shares are owned by company insiders. Comparatively, 0.8% of Badger Meter shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Dividends

Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.2%. Badger Meter pays an annual dividend of $0.72 per share and has a dividend yield of 0.8%. Mesa Laboratories pays out 15.2% of its earnings in the form of a dividend. Badger Meter pays out 44.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Mesa Laboratories has raised its dividend for 1 consecutive years and Badger Meter has raised its dividend for 19 consecutive years. Badger Meter is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk & Volatility

Mesa Laboratories has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Comparatively, Badger Meter has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Profitability

This table compares Mesa Laboratories and Badger Meter's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Mesa Laboratories-2.04%6.39%3.91%
Badger Meter11.53%14.28%11.15%

Summary

Badger Meter beats Mesa Laboratories on 10 of the 16 factors compared between the two stocks.


Mesa Laboratories Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Cognex logo
CGNX
Cognex
1.9$83.23+1.1%$14.70 billion$725.63 million78.52News Coverage
FLIR Systems logo
FLIR
FLIR Systems
1.5$57.99+0.3%$7.61 billion$1.89 billion55.23Increase in Short Interest
Coherent logo
COHR
Coherent
1.5$268.66+0.7%$6.57 billion$1.23 billion-15.63Analyst Downgrade
Increase in Short Interest
National Instruments logo
NATI
National Instruments
1.5$44.23+0.4%$5.82 billion$1.35 billion29.49
Itron logo
ITRI
Itron
1.7$89.48+1.4%$4.04 billion$2.50 billion-55.23News Coverage
Badger Meter logo
BMI
Badger Meter
2.0$95.15+0.7%$2.77 billion$424.63 million56.98Upcoming Earnings
News Coverage
OSI Systems logo
OSIS
OSI Systems
1.6$96.62+0.2%$1.74 billion$1.17 billion28.01
FARO Technologies logo
FARO
FARO Technologies
1.6$85.60+0.2%$1.54 billion$381.77 million-19.63
MTS Systems logo
MTSC
MTS Systems
0.9$58.49+0.0%$1.14 billion$828.59 million-4.14
Vishay Precision Group logo
VPG
Vishay Precision Group
2.1$31.04+0.0%$422.45 million$283.96 million29.28
Daktronics logo
DAKT
Daktronics
0.7$6.41+0.9%$402.23 million$608.93 million-128.20News Coverage
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.